The mitochondrial permeability transition in neurologic disease

Mitochondria, being the principal source of cellular energy, are vital for cell life. Yet, ironically, they are also major mediators of cell death, either by necrosis or apoptosis. One means by which these adverse effects occur is through the mitochondrial permeability transition (mPT) whereby the inner mitochondrial membrane suddenly becomes excessively permeable to ions and other solutes, resulting in a collapse of the inner membrane potential, ultimately leading to energy failure and cell necrosis. The mPT may also bring about the release of various factors known to cause apoptotic cell death. The principal factors leading to the mPT are elevated levels of intracellular Ca2+ and oxidative stress. Characteristically, the mPT is inhibited by cyclosporin A. This article will briefly discuss the concept of the mPT, its molecular composition, its inducers and regulators, agents that influence its activity and describe the consequences of its induction. Lastly, we will review its potential contribution to acute neurological disorders, including ischemia, trauma, and toxic-metabolic conditions, as well as its role in chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis.

[1]  A. Marmarou,et al.  The protective effect of cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. , 2004, Journal of neurotrauma.

[2]  S. Hersch,et al.  The Cellular and Subcellular Localization of Huntingtin-Associated Protein 1 (HAP1): Comparison with Huntingtin in Rat and Human , 1998, The Journal of Neuroscience.

[3]  S. Orrenius,et al.  Calcineurin and mitochondrial function in glutamate‐induced neuronal cell death , 1996, FEBS letters.

[4]  M. Beal,et al.  Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity , 1998, Experimental Neurology.

[5]  I. Reynolds,et al.  Ca2+‐induced permeabilization promotes free radical release from rat brain mitochondria with partially inhibited complex I , 2005, Journal of neurochemistry.

[6]  T. Wallimann,et al.  Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain. , 1996, Biochimica et biophysica acta.

[7]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[8]  M. Zoratti,et al.  The mitochondrial permeability transition pore may comprise VDAC molecules , 1993, FEBS letters.

[9]  A. Pérez-Bouza,et al.  Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue , 2005, Neuroscience.

[10]  B. Winblad,et al.  Nicastrin, Presenilin, APH-1, and PEN-2 Form Active γ-Secretase Complexes in Mitochondria* , 2004, Journal of Biological Chemistry.

[11]  Protein oxidation and age-dependent alterations in calcium homeostasis. , 2000 .

[12]  R. Raghupathi,et al.  Cell Death Mechanisms Following Traumatic Brain Injury , 2004, Brain pathology.

[13]  M. MacDonald,et al.  Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. , 2004, Human molecular genetics.

[14]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[15]  S. Snyder,et al.  Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization , 1999, Nature Medicine.

[16]  M. Murányi,et al.  Bongkrekic acid ameliorates ischemic neuronal death in the cortex by preventing cytochrome c release and inhibiting astrocyte activation , 2005, Neuroscience Letters.

[17]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. , 1979, Archives of biochemistry and biophysics.

[18]  B. Antonsson,et al.  Activation of calcium‐independent phospholipase A2 (iPLA2) in brain mitochondria and release of apoptogenic factors by BAX and truncated BID , 2005, Journal of neurochemistry.

[19]  M. Crompton,et al.  Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. , 1988, The Biochemical journal.

[20]  A. Halestrap,et al.  Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. , 1998, The Biochemical journal.

[21]  Ole A. Andreassen,et al.  Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.

[22]  B. Siesjö,et al.  Acidosis promotes the permeability transition in energized mitochondria: implications for reperfusion injury. , 2001, Journal of neurotrauma.

[23]  Michael Aschner,et al.  Manganese Uptake and Efflux in Cultured Rat Astrocytes , 1992, Journal of neurochemistry.

[24]  A. Hansen,et al.  Extracellular ion concentrations during spreading depression and ischemia in the rat brain cortex. , 1981, Acta physiologica Scandinavica.

[25]  P. Mecocci,et al.  Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain , 1993, Annals of neurology.

[26]  F. Menzies,et al.  Mitochondrial involvement in amyotrophic lateral sclerosis , 2002, Neurochemistry International.

[27]  O. Hansson,et al.  Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents , 2003, Experimental Neurology.

[28]  H. Kimelberg,et al.  Neuroprotective activity of tamoxifen in permanent focal ischemia. , 2003, Journal of neurosurgery.

[29]  M. Norenberg,et al.  Differential response of glutamine in cultured neurons and astrocytes , 2005, Journal of neuroscience research.

[30]  F. Plum,et al.  Biochemistry and physiology of brain ammonia. , 1987, Physiological reviews.

[31]  M. Beal,et al.  Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology , 2004, The Journal of experimental medicine.

[32]  T. Hurd,et al.  Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology , 2005, Biochemistry (Moscow).

[33]  Ole A. Andreassen,et al.  Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease , 2000, The Journal of Neuroscience.

[34]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. Kopin,et al.  Features of the Dopaminergic Neurotoxin MPTP , 1992, Annals of the New York Academy of Sciences.

[36]  M. Norenberg A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. , 1977, Laboratory investigation; a journal of technical methods and pathology.

[37]  F. Joó,et al.  Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophc lateral sclerosis , 1996, Annals of neurology.

[38]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[39]  M. Crompton,et al.  Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. , 1998, European journal of biochemistry.

[40]  Zuoshang Xu,et al.  Mutant Cu, Zn Superoxide Dismutase that Causes Motoneuron Degeneration Is Present in Mitochondria in the CNS , 2002, The Journal of Neuroscience.

[41]  M. Mattson,et al.  Increased Sensitivity to Mitochondrial Toxin-Induced Apoptosis in Neural Cells Expressing Mutant Presenilin-1 Is Linked to Perturbed Calcium Homeostasis and Enhanced Oxyradical Production , 1998, The Journal of Neuroscience.

[42]  M. Duchen Roles of mitochondria in health and disease. , 2004, Diabetes.

[43]  M. Beal,et al.  Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity , 2005, Neurobiology of Disease.

[44]  A. Nunomura,et al.  Oxidative damage in Alzheimer’s disease: the metabolic dimension , 2000, International Journal of Developmental Neuroscience.

[45]  G Fiskum,et al.  Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  C. Rodrigues,et al.  Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. , 2001, Biochemical and biophysical research communications.

[47]  W. Craigen,et al.  Properties of the permeability transition in VDAC1(-/-) mitochondria. , 2006, Biochimica et biophysica acta.

[48]  M. Beal Huntington's disease, energy, and excitotoxicity , 1994, Neurobiology of Aging.

[49]  A. Halestrap Calcium, mitochondria and reperfusion injury: a pore way to die. , 2006, Biochemical Society transactions.

[50]  D. Okonkwo,et al.  The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. , 2001, Journal of neurotrauma.

[51]  A. F. Schinder,et al.  Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.

[52]  D. Brdiczka,et al.  Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. , 1998, Biochimica et biophysica acta.

[53]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[54]  M. Zoratti,et al.  Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. , 1992, The Journal of biological chemistry.

[55]  Y. Akao,et al.  Mitochondrial permeability transition mediates apoptosis induced by N‐methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, N‐propargyl‐1(R)‐aminoindan , 2002, Journal of neurochemistry.

[56]  A. Halestrap,et al.  Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. , 1990, The Biochemical journal.

[57]  Y. Hatefi The mitochondrial electron transport and oxidative phosphorylation system. , 1985, Annual review of biochemistry.

[58]  J. Holstege,et al.  CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations , 2001, Acta Neuropathologica.

[59]  A Wennberg,et al.  Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure. , 1992, Neurotoxicology.

[60]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[61]  F. Poccia,et al.  Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH‐SY5Y cells , 1997, FEBS letters.

[62]  M. Norenberg,et al.  Glutamine‐induced free radical production in cultured astrocytes , 2004, Glia.

[63]  James R. Burke,et al.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.

[64]  C. Dixon,et al.  Molecular mechanisms in the pathogenesis of traumatic brain injury. , 2002, Histology and histopathology.

[65]  W. Burke,et al.  Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. , 2001, Free radical biology & medicine.

[66]  T. Wallimann,et al.  The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition , 1998, BioFactors.

[67]  A. Toninello,et al.  On the relationship between calcium and phosphate transport, transmembrane potential and acetoacetate-induced oxidation of pyridine nucleotides in rat-liver mitochondria. , 2005, European journal of biochemistry.

[68]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[69]  M. Norenberg,et al.  Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine , 2003, Neurochemistry International.

[70]  T. Wieloch,et al.  Mitochondrial permeability transition in acute neurodegeneration. , 2002, Biochimie.

[71]  M. Beal,et al.  Bioenergetic approaches for neuroprotection in Parkinson's disease , 2003, Annals of neurology.

[72]  Jeffrey D. Rothstein,et al.  From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.

[73]  A. Halestrap,et al.  Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. , 1991, The Biochemical journal.

[74]  S. Scheff,et al.  Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. , 1999, Journal of neurotrauma.

[75]  J. Zuo,et al.  Glucose deprivation induces mitochondrial dysfunction and oxidative stress in PC12 cell line , 2003, Journal of cellular and molecular medicine.

[76]  M. Beal,et al.  Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice* , 2002, The Journal of Biological Chemistry.

[77]  G. Miotto,et al.  Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. , 1999, Biophysical journal.

[78]  P. Leigh,et al.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[79]  S. Snyder,et al.  p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.

[80]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[81]  J. Cooper,et al.  Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins , 1998, Brain Research.

[82]  J. Parks,et al.  Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro , 2001, Journal of neurochemistry.

[83]  S. Korsmeyer,et al.  Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[84]  M. Goldberg,et al.  Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[85]  C. Behl Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches , 1999, Progress in Neurobiology.

[86]  K. Gunter,et al.  Uptake of Calcium by Mitochondria: Transport and Possible Function , 2001, IUBMB life.

[87]  H. Tedeschi THE MITOCHONDRIAL MEMBRANE POTENTIAL , 1980, Biological reviews of the Cambridge Philosophical Society.

[88]  T. Sherer,et al.  The rotenone model of Parkinson's disease: genes, environment and mitochondria. , 2003, Parkinsonism & related disorders.

[89]  K. Csiszȧr,et al.  Intrathecal cyclosporin prolongs survival of late-stage ALS mice , 2001, Brain Research.

[90]  M. Mather,et al.  Aging Enhances the Activation of the Permeability Transition Pore in Mitochondria , 2000, Biochemical and biophysical research communications.

[91]  M. Beal,et al.  Bioenergetics in Huntington's Disease , 1999, Annals of the New York Academy of Sciences.

[92]  Jeffrey Robbins,et al.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.

[93]  D. Okonkwo,et al.  Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. , 1999, Journal of neurotrauma.

[94]  D. Okonkwo,et al.  Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. , 1999, Neuroreport.

[95]  J M Dubinsky,et al.  Calcium‐induced activation of the mitochondrial permeability transition in hippocampal neurons , 1998, Journal of neuroscience research.

[96]  M. Gomez-Lazaro,et al.  Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS‐dependent pathway , 2005, British journal of pharmacology.

[97]  R. Butterworth,et al.  Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy. , 1993, Metabolism: clinical and experimental.

[98]  M. Beal,et al.  Oxidative Stress in Huntington's Disease , 1999, Brain pathology.

[99]  T. Wallimann,et al.  Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore , 1998, FEBS letters.

[100]  M. Duchen,et al.  β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase , 2004, The Journal of Neuroscience.

[101]  J. Parks,et al.  The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. , 1999, Biochimica et biophysica acta.

[102]  Jason P. Sheehan,et al.  Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[103]  T. Wieloch,et al.  Blockade of the Mitochondrial Permeability Transition Pore Diminishes Infarct Size in the Rat after Transient Middle Cerebral Artery Occlusion , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[104]  B. Siesjö,et al.  Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. (1992). , 2008, Journal of neurosurgery.

[105]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[106]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Claire-Anne Gutekunst,et al.  A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.

[108]  Whetsell Wo,et al.  Neuroexcitation, excitotoxicity and human neurological disease , 1993 .

[109]  J. Simard,et al.  Suppression of ammonia‐induced astrocyte swelling by cyclosporin A , 2003, Journal of neuroscience research.

[110]  A. Halestrap,et al.  Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury , 1997 .

[111]  Lihua He,et al.  Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? , 2002, FEBS letters.

[112]  M. Crompton On the involvement of mitochondrial intermembrane junctional complexes in apoptosis. , 2003, Current medicinal chemistry.

[113]  M. Zoratti,et al.  The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.

[114]  P. Schauwecker,et al.  Protection Provided by Cyclosporin A against Excitotoxic Neuronal Death Is Genotype Dependent , 2003, Epilepsia.

[115]  J. Kong,et al.  Mitochondrial Degeneration in Amyotrophic Lateral Sclerosis , 2004, Journal of bioenergetics and biomembranes.

[116]  M. Norenberg,et al.  Oxidative Stress and Mitogen-Activated Protein Kinase Phosphorylation Mediate Ammonia-Induced Cell Swelling and Glutamate Uptake Inhibition in Cultured Astrocytes , 2006, The Journal of Neuroscience.

[117]  M. Rice,et al.  Brain edema induced by in vitro ischemia: causal factors and neuroprotection , 2003, Journal of neurochemistry.

[118]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[119]  Alexander Sasha Rabchevsky,et al.  Intrinsic differences in brain and spinal cord mitochondria: Implication for therapeutic interventions , 2004, The Journal of comparative neurology.

[120]  B. Siesjö Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. , 1992, Journal of neurosurgery.

[121]  M. Crompton,et al.  Mitochondrial intermembrane junctional complexes and their involvement in cell death. , 2002, Biochimie.

[122]  K. Csiszȧr,et al.  Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. , 2004, Journal of neurosurgery.

[123]  A E Vercesi,et al.  Mitochondrial permeability transition and oxidative stress , 2001, FEBS letters.

[124]  J. Dubinsky,et al.  On the mechanisms of neuroprotection by creatine and phosphocreatine , 2001, Journal of neurochemistry.

[125]  W. Strittmatter,et al.  In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. , 2003, Archives of biochemistry and biophysics.

[126]  G. Sobue,et al.  Mitochondrial Localization of Mutant Superoxide Dismutase 1 Triggers Caspase-dependent Cell Death in a Cellular Model of Familial Amyotrophic Lateral Sclerosis* , 2002, The Journal of Biological Chemistry.

[127]  M. Beal,et al.  Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase , 2004, Neurobiology of Disease.

[128]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[129]  P. Puttfarcken,et al.  Inhibition of Age-Induced β-Amyloid Neurotoxicity in Rat Hippocampal Cells , 1996, Experimental Neurology.

[130]  B. Hyman,et al.  Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate , 1993, Journal of neurochemistry.

[131]  P. Bernardi,et al.  Properties of the Permeability Transition Pore in Mitochondria Devoid of Cyclophilin D* , 2005, Journal of Biological Chemistry.

[132]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[133]  D. Nicholls Mitochondria and calcium signaling. , 2005, Cell calcium.

[134]  A. Nieminen Apoptosis and necrosis in health and disease: role of mitochondria. , 2003, International review of cytology.

[135]  W. Schubert,et al.  Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). , 1971, The New England journal of medicine.

[136]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[137]  B. Siesjö Acid-base homeostasis in the brain: physiology, chemistry, and neurochemical pathology. , 1985, Progress in brain research.

[138]  S. Hersch,et al.  Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease , 2000, Nature Medicine.

[139]  A. Halestrap,et al.  Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. , 1999, American journal of physiology. Heart and circulatory physiology.

[140]  Betty Y. S. Kim,et al.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.

[141]  M. MacDonald,et al.  Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. , 2004, Human molecular genetics.

[142]  P. Moreira,et al.  Effect of amyloid β‐peptide on permeability transition pore: A comparative study , 2002 .

[143]  C. Oliveira,et al.  Mitochondrial function impairment induced by amyloid β‐peptide on PC12 cells , 1998 .

[144]  P. Moreira,et al.  Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen , 2005, Neuropharmacology.

[145]  D. Selkoe,et al.  Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.

[146]  O. Andreassen,et al.  Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease , 2001, Neurobiology of Disease.

[147]  J. Lemasters,et al.  The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury. , 1996, The Journal of pharmacology and experimental therapeutics.

[148]  C. Brenner,et al.  The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. , 2003, Current medicinal chemistry.

[149]  T. Kristian Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. , 2004, Cell calcium.

[150]  Tetsuya Watanabe,et al.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.

[151]  R. Auer,et al.  Biological differences between ischemia, hypoglycemia, and epilepsy , 1988, Annals of neurology.

[152]  Zuoshang Xu,et al.  ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes , 2003, BMC Neuroscience.

[153]  M. Norenberg,et al.  Manganese Induces the Mitochondrial Permeability Transition in Cultured Astrocytes* , 2004, Journal of Biological Chemistry.

[154]  I. Sayeed,et al.  Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti‐apoptotic effects of melatonin , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[155]  B. Siesjö,et al.  Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat , 2001, Brain Research.

[156]  D. Bonthron,et al.  Platelet-derived growth factor A-chain gene transcription is mediated by positive and negative regulatory regions in the promoter. , 1994, The Biochemical journal.

[157]  K. Weissenborn,et al.  Neurology and the liver , 1997, Journal of neurology, neurosurgery, and psychiatry.

[158]  Dean P. Jones,et al.  The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore , 2004, Nature.

[159]  Bruce R. Rosen,et al.  Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease , 1998, The Journal of Neuroscience.

[160]  M. Norenberg,et al.  Fine structural localization of glutamine synthetase in astrocytes of rat brain , 1979, Brain Research.

[161]  M. Norenberg,et al.  Ammonia Neurotoxicity: Role of the Mitochondrial Permeability Transition , 2003, Metabolic Brain Disease.

[162]  I. Fridovich,et al.  Subcellular Distribution of Superoxide Dismutases (SOD) in Rat Liver , 2001, The Journal of Biological Chemistry.

[163]  M. Norenberg,et al.  Oxidative Stress in the Pathogenesis of Hepatic Encephalopathy , 2004, Metabolic Brain Disease.

[164]  M. Norenberg Astroglial Dysfunction in Hepatic Encephalopathy , 1998, Metabolic Brain Disease.

[165]  J. Kaiser Manganese: A High-Octane Dispute , 2003, Science.

[166]  F. Ichas,et al.  A Ubiquinone-binding Site Regulates the Mitochondrial Permeability Transition Pore* , 1998, The Journal of Biological Chemistry.

[167]  O. Andreassen,et al.  Malonate and 3‐Nitropropionic Acid Neurotoxicity Are Reduced in Transgenic Mice Expressing a Caspase‐1 Dominant‐Negative Mutant , 2000, Journal of neurochemistry.

[168]  C. Rose,et al.  Acute Insult of Ammonia Leads to Calcium-dependent Glutamate Release from Cultured Astrocytes, an Effect of pH* , 2005, Journal of Biological Chemistry.

[169]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[170]  M. Norenberg,et al.  Ammonia‐induced production of free radicals in primary cultures of rat astrocytes , 2001, Journal of neuroscience research.

[171]  J. Baldassare,et al.  Molecular aspects of Huntington's disease , 1998, Journal of neuroscience research.

[172]  S. Budd,et al.  Mitochondria and neuronal survival. , 2000, Physiological reviews.

[173]  A. Koretsky,et al.  The role of creatine kinase in inhibition of mitochondrial permeability transition , 1997, FEBS letters.

[174]  S. Scheff,et al.  Cyclosporin A Attenuates Acute Mitochondrial Dysfunction Following Traumatic Brain Injury , 1999, Experimental Neurology.

[175]  A. Hazell,et al.  Hepatic Encephalopathy: An Update of Pathophysiologic Mechanisms (44433A) , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[176]  A. Lehninger,et al.  Regulation of Ca2+ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[177]  David Blum,et al.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.

[178]  A. Halestrap,et al.  Oxidative Stress, Thiol Reagents, and Membrane Potential Modulate the Mitochondrial Permeability Transition by Affecting Nucleotide Binding to the Adenine Nucleotide Translocase* , 1997, The Journal of Biological Chemistry.

[179]  S. Maruyama,et al.  Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease , 1990, Journal of the Neurological Sciences.

[180]  R. Ramsay,et al.  Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas. , 1993, Advances in neurology.

[181]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[182]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[183]  N. A. Solovyova,et al.  Impairment of respiratory functions in mitochondria of rats with an inherited hyperproduction of free radicals. , 1994, Biochemical and biophysical research communications.

[184]  B. Siesjö,et al.  Cerebral Extracellular Calcium Activity in Severe Hypoglycemia: Relation to Extracellular Potassium and Energy State , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[185]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[186]  J. Quinn,et al.  Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.

[187]  M. Norenberg,et al.  Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes , 2001, Journal of neuroscience research.

[188]  T. Koike,et al.  Early apoptotic and late necrotic components associated with altered Ca2+ homeostasis in a peptide‐delivery model of polyglutamine‐induced neuronal death , 2005, Journal of neuroscience research.

[189]  I. Reynolds,et al.  Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.

[190]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[191]  S. Paul,et al.  Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[192]  M. Murphy,et al.  Exposure to the parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. , 1996, Biochemical pharmacology.

[193]  M. Beal,et al.  Excitotoxicity and nitric oxide in parkinson's disease pathogenesis , 1998, Annals of neurology.

[194]  V. Shoshan-Barmatz,et al.  The voltage-dependent anion channel , 2007, Cell Biochemistry and Biophysics.

[195]  S. Snyder,et al.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[196]  Yangzheng Feng,et al.  Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats. , 2004, European journal of pharmacology.

[197]  K. Beyreuther,et al.  Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.

[198]  F. Checler Presenilins: structural aspects and posttranslational events. , 1999, Molecular neurobiology.

[199]  D. Ganger,et al.  Electron microscopic evaluation of brain edema in rabbits with galactosamine‐induced fulminant hepatic failure: Ultrastructure and integrity of the blood‐brain barrier , 1987, Hepatology.

[200]  M. Mattson,et al.  Pivotal Role of Mitochondrial Calcium Uptake in Neural Cell Apoptosis and Necrosis , 1999, Journal of neurochemistry.

[201]  D. Choi Excitotoxic cell death. , 1992, Journal of neurobiology.

[202]  R. Rosenthal,et al.  Mechanisms of Ischemic Neuroprotection by Acetyl‐l‐carnitine , 2005, Annals of the New York Academy of Sciences.

[203]  M. Norenberg,et al.  Mechanisms of Ammonia-Induced Astrocyte Swelling , 2005, Metabolic Brain Disease.

[204]  L. Raymond,et al.  Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease , 2004, Molecular and Cellular Neuroscience.

[205]  D. Cassarino,et al.  An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration , 1999, Brain Research Reviews.

[206]  T. Wieloch,et al.  Cyclosporin A, But Not FK 506, Protects Mitochondria and Neurons against Hypoglycemic Damage and Implicates the Mitochondrial Permeability Transition in Cell Death , 1998, The Journal of Neuroscience.

[207]  J. Julien,et al.  Amyotrophic Lateral Sclerosis Unfolding the Toxicity of the Misfolded , 2001, Cell.

[208]  L. Dugan,et al.  The Mitochondrial Permeability Transition Pore and Nitric Oxide Synthase Mediate Early Mitochondrial Depolarization in Astrocytes during Oxygen–Glucose Deprivation , 2001, The Journal of Neuroscience.

[209]  M. Norenberg,et al.  Glutamine: A Trojan horse in ammonia neurotoxicity , 2006, Hepatology.

[210]  M. Klingenberg,et al.  Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. , 1996, Biochemistry.

[211]  T. Wieloch,et al.  Cyclosporin A and its nonimmunosuppressive analogue N‐Me‐Val‐4‐cyclosporin A mitigate glucose/oxygen deprivation‐induced damage to rat cultured hippocampal neurons , 1999, The European journal of neuroscience.

[212]  R. Jemmerson,et al.  Cytochrome C release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases. , 2005, Antioxidants & redox signaling.

[213]  J. Satrústegui,et al.  Cyclosporin A targets involved in protection against glutamate excitotoxicity. , 2000, European journal of pharmacology.

[214]  A. Halestrap,et al.  Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. , 1994, The Biochemical journal.

[215]  R. Ferrante,et al.  Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[216]  Alexander Sasha Rabchevsky,et al.  Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. , 2001, Journal of neurotrauma.

[217]  M. Robin,et al.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells , 2003, The Journal of cell biology.

[218]  Y. Wei,et al.  Liver mitochondrial respiratory functions decline with age. , 1989, Biochemical and biophysical research communications.

[219]  M. Norenberg,et al.  Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes , 2005, Neurochemistry International.